Back to User profile » Dr Hiroshi Koto
Paper published by Dr Hiroshi Koto:
Original Research
Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial
Machida K, Kawayama T, Kinoshita M, Ichinose M, Tsuda T, Takata S, Koto H, Yoshida M, Ashihara Y, Kawashima M, Suna H, Inoue H
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2175-2184
Published Date: 19 September 2019